Did Anything Support Bellicum (BLCM) Stock Last Trading?
ST Staff
June 25, 2021
After-hours trade on Thursday saw Bellicum Pharmaceuticals Inc. (BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, plunge -0.57% at $3.46. BLCM stock